Further, APOBEC3A rs1014971 was not associated with bile duct cancer compared to healthy controls but increased the risk of CCA in patients with inflammatory biliary diseases (cholangitis, cholecystitis, bile duct stone, gallstone and choledochal cyst). Here, APOBEC3A is linked to Cholecystitis.